Medical devices, healthcare technology and the business of care
510(k) clearance · K263063

B`orze Inc Laser Family (Sorren/Adonis)

Borze, Inc. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK263063

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 10/30/2026 for K263063, submitted by Borze, Inc. of Boise, Idaho, covering the device named B`orze Inc Laser Family (Sorren/Adonis). The application was received 09/01/2026 and listed as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The classification is Powered Laser Surgical Instrument under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty and review panel.

SESE in a 510(k) means the device was found substantially equivalent to a legally marketed predicate and cleared to market; it is not a PMA approval. The public record identifies Shenzhen Hlongmed Biotech Co., Ltd. as correspondent, with Long Yang as correspondent contact. The record does not state which laser components, models, or specific changes were assessed, nor the predicate device, so the technical basis for equivalence remains unknown from these fields.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263063
Regulatory pathway
510(k) premarket notification
Applicant
Borze, Inc.
Product code
GEX
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powered Laser Surgical Instrument.

Applicant
Borze, Inc.
Product code
GEX
FDA device class
2

FDA decision timeline

  1. K263063 received

    Application receipt date recorded by FDA.

  2. K263063 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Borze, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Boise, ID

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records